CNC fosters entrepreneurship and innovation by valorising the scientific and technological knowledge developed in our laboratories and investing in cutting-edge infrastructures and qualified professionals. The biomedical and biotechnological nature of the research performed at CNC brings additional responsibility towards the society, namely the local community. As such, CNC is committed to transfer the technologies and products developed at our institute to local industries and organizations towards regional development.

The privileged position of CNC in the central region of Portugal, situated within the academic environment of Universidade de Coimbra campus and the innovative Biocant Technological Park, contributes to dynamic Technology Transfer in place at our institute.

CNC is actively engaged with IP protection with a total of 30 patents under PCT and over 10 licensing agreements. Technology transfer efforts, which originated 14 new spin-offs/start-ups including MitoTAG, Exogenus-T, Matera and CureMat Technologies, raised ca. 6 Million euros of investment. Contract projects were established in Portugal - Bial, Bluepharma, Crioestaminal - and elsewhere - Bioblast, Merck, INNOTECH.
Funded by ERDF - European Regional Development Fund through COMPETE 2020 and National Funds via FCT - Fundação para a Ciência e Tecnologia, under projects POCI-01-0145-FEDER-007440 e UIDB/04539/2020.

© 2021 CNC - Center for Neuroscience and Cell Biology
powered by DigitalWind